Concord Drugs
89.75
+1.37(+1.55%)
Market Cap₹89.77 Cr
PE Ratio152.38
IndustryHealthcare
Company Performance:
1D+1.55%
1M+18.87%
6M+78.22%
1Y+140.10%
5Y+290.22%
View Company Insightsright
More news about Concord Drugs
30Jun 25
Concord Drugs to Hold Board Meeting on Fundraising Initiatives
Concord Drugs Ltd has announced a board meeting on July 3 to discuss fundraising and capital raising initiatives. The meeting signals the company's active consideration of strategies to strengthen its financial position, which could potentially support various aspects of operations such as research and development, facility expansion, market growth, debt reduction, or working capital requirements.
Concord Drugs
89.75
+1.37
(+1.55%)
1 Year Returns:+140.10%
Industry Peers
Sun Pharmaceutical
1,776.50
(+0.93%)
Divis Laboratories
6,683.50
(+0.62%)
Torrent Pharmaceuticals
4,024.60
(+2.23%)
Cipla
1,476.50
(-3.55%)
Dr Reddys Laboratories
1,254.90
(-0.10%)
Lupin
2,209.40
(+2.78%)
Mankind Pharma
2,286.00
(+2.02%)
Zydus Life Science
933.00
(+0.21%)
Aurobindo Pharma
1,254.60
(+1.89%)
Alkem Laboratories
5,789.50
(+2.37%)